Growth Equity Opportunities IV, LLC insider trades: Aveo Pharmaceuticals (AVEO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Growth Equity Opportunities IV, LLC reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 19, 2020 | AVEO | ↑ Buy | 1,428,571 | $5.25 | $7.5M | Direct | Jun 22, 2020 (3d) |
| Apr 8, 2019 | AVEO | ↑ Buy | 4,347,827 | $1.14 | $5.0M | Direct | Apr 8, 2019 (0d) |
| Dec 21, 2018 | AVEO | ↑ Buy | 500,000 | $1.55 | $774K | Direct | Dec 21, 2018 (0d) |
| Dec 11, 2018 | AVEO | ↑ Buy | 61,200 | $1.98 | $121K | Direct | Dec 12, 2018 (1d) |
| Dec 10, 2018 | AVEO | ↑ Buy | 170,400 | $1.99 | $338K | Direct | Dec 10, 2018 (0d) |
| Nov 30, 2018 | AVEO | ↑ Buy | 96,400 | $1.98 | $191K | Direct | Nov 30, 2018 (0d) |
| Nov 20, 2018 | AVEO | ↑ Buy | 170,000 | $1.98 | $336K | Direct | Nov 21, 2018 (1d) |
| Nov 19, 2018 | AVEO | ↑ Buy | 1,200,000 | $1.86 | $2.2M | Direct | Nov 19, 2018 (0d) |
| Aug 21, 2018 | AVEO | ↑ Buy | 663,716 | $2.26 | $1.5M | Direct | Aug 22, 2018 (1d) |
| Jul 19, 2018 | AVEO | ↑ Buy | 250,600 | $1.96 | $492K | Direct | Jul 20, 2018 (1d) |
| Jun 28, 2018 | AVEO | ↑ Buy | 192,425 | $2.10 | $404K | Direct | Jun 28, 2018 (0d) |
| May 30, 2018 | AVEO | ↑ Buy | 275 | $2.15 | $591 | Direct | May 30, 2018 (0d) |
| May 21, 2018 | AVEO | ↑ Buy | 236,479 | $2.13 | $503K | Direct | May 21, 2018 (0d) |
| May 8, 2018 | AVEO | ↑ Buy | 70,873 | $2.13 | $151K | Direct | May 10, 2018 (2d) |
| Apr 10, 2018 | AVEO | ↑ Buy | 920,976 | $2.30 | $2.1M | Direct | Apr 10, 2018 (0d) |
| Feb 26, 2018 | ABIO | ↓ Sell | 1,460,209 | $0.50 | $731K | Direct | Feb 27, 2018 (1d) |
| Mar 28, 2017 | AVEO | ↑ Buy | 6,000,000 | $0.50 | $3.0M | Direct | Mar 29, 2017 (1d) |
| Dec 19, 2016 | AKAO | ↑ Buy | 500,000 | $13.50 | $6.8M | Direct | Dec 19, 2016 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Growth Equity Opportunities IV, LLC's insider trades
Growth Equity Opportunities IV, LLC is a 10% owner of Aveo Pharmaceuticals (AVEO). Since Dec 19, 2016, it has reported 17 open-market purchases worth $31.4M and 1 sale worth $731K on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (3 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVEO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.